Paushak Ltd
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]
- Market Cap ₹ 1,984 Cr.
- Current Price ₹ 805
- High / Low ₹ 991 / 468
- Stock P/E 38.8
- Book Value ₹ 189
- Dividend Yield 0.31 %
- ROCE 11.2 %
- ROE 9.76 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 8.87% over past five years.
- Company has a low return on equity of 12.3% over last 3 years.
- Dividend payout has been low at 11.3% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
54 | 69 | 78 | 72 | 105 | 140 | 138 | 141 | 150 | 212 | 206 | 211 | 215 | |
43 | 52 | 61 | 60 | 75 | 99 | 95 | 91 | 96 | 137 | 142 | 151 | 149 | |
Operating Profit | 11 | 17 | 17 | 12 | 29 | 40 | 43 | 50 | 54 | 75 | 65 | 60 | 65 |
OPM % | 20% | 25% | 22% | 17% | 28% | 29% | 31% | 36% | 36% | 35% | 31% | 28% | 30% |
4 | 3 | 3 | 5 | 3 | 13 | 7 | 6 | 5 | 11 | 20 | 14 | 12 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 9 | 13 | 14 | 15 | 15 |
Profit before tax | 13 | 18 | 17 | 14 | 29 | 49 | 45 | 52 | 50 | 72 | 71 | 59 | 62 |
Tax % | 30% | 28% | 25% | 22% | 26% | 20% | 23% | 28% | 25% | 25% | 23% | 16% | |
9 | 13 | 12 | 11 | 21 | 39 | 35 | 37 | 38 | 54 | 54 | 49 | 51 | |
EPS in Rs | 3.45 | 5.07 | 4.85 | 4.27 | 8.39 | 15.84 | 14.19 | 15.16 | 15.29 | 21.96 | 22.09 | 20.07 | 20.76 |
Dividend Payout % | 11% | 7% | 8% | 9% | 4% | 4% | 5% | 5% | 10% | 10% | 11% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 9% |
3 Years: | 12% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 6% |
3 Years: | 5% |
TTM: | -8% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 10% |
3 Years: | -10% |
1 Year: | 22% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 13% |
3 Years: | 12% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 42 | 54 | 65 | 80 | 110 | 174 | 224 | 269 | 302 | 351 | 405 | 462 |
0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 25 | |
8 | 11 | 13 | 11 | 31 | 36 | 43 | 57 | 61 | 61 | 73 | 81 | |
Total Liabilities | 54 | 69 | 82 | 94 | 144 | 214 | 270 | 329 | 367 | 415 | 481 | 572 |
9 | 18 | 20 | 35 | 37 | 38 | 41 | 51 | 147 | 149 | 152 | 141 | |
CWIP | 4 | 1 | 12 | 0 | 1 | 6 | 16 | 68 | 8 | 7 | 29 | 190 |
Investments | 18 | 19 | 18 | 33 | 53 | 116 | 163 | 154 | 151 | 182 | 223 | 139 |
23 | 30 | 31 | 26 | 54 | 54 | 50 | 56 | 61 | 78 | 77 | 102 | |
Total Assets | 54 | 69 | 82 | 94 | 144 | 214 | 270 | 329 | 367 | 415 | 481 | 572 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | 9 | 14 | 12 | 10 | 24 | 45 | 30 | 44 | 43 | 56 | 38 | |
-7 | -8 | -13 | -11 | -10 | -0 | -43 | -29 | -42 | -38 | -50 | -57 | |
-2 | -1 | -1 | -2 | -1 | -23 | -2 | -2 | -2 | -4 | -5 | 19 | |
Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -1 | -0 | 0 | 0 | -1 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 96 | 114 | 97 | 83 | 135 | 85 | 69 | 85 | 97 | 90 | 90 | 94 |
Inventory Days | 117 | 96 | 117 | 125 | 118 | 122 | 131 | 148 | 233 | 180 | 177 | 179 |
Days Payable | 71 | 94 | 104 | 70 | 170 | 73 | 110 | 118 | 227 | 122 | 130 | 167 |
Cash Conversion Cycle | 142 | 116 | 110 | 138 | 83 | 133 | 89 | 115 | 103 | 149 | 137 | 107 |
Working Capital Days | 108 | 108 | 92 | 92 | 107 | 100 | 75 | 60 | 81 | 93 | 84 | 80 |
ROCE % | 30% | 32% | 25% | 12% | 29% | 27% | 21% | 20% | 17% | 21% | 17% | 11% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment
1d - Allotted 1,84,92,684 bonus shares (3:1); paid-up capital increased to Rs.12,32,84,560. Deemed allotment 6 Oct 2025.
-
Intimation For Change In Email Address Of The Registrar And Share Transfer Agent ('RTA') Of The Company
1 Oct - MIIPL introduced new generic investor email investor.helpdesk@in.mpms.mufg.com effective 1 Oct 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 Sep - Paper cuttings of newspaper advertisement issued regarding a campaign launched by IEPFA and MCA, titled as "Saksham Niveshak".
-
Closure of Trading Window
26 Sep - Trading window closed Oct 1, 2025 until 48 hours after unaudited Q2/H1 results for Sept 30, 2025.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 18 Sep
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Products Offered
Paushak is part of the Alembic group of companies situated in Gujarat, India and is the largest specialty chemical company in India based on Phosgene Chemistry. Its products include Chloroformates, Isocyanates, Chlorides, Carbonates/Carbamate and Other Chemicals. These chemicals are used in diverse fields such as pesticides, pharmaceuticals dyes plastics and perfumeries. [1] [2]